دورية أكاديمية

Comparison of Atipamezole with Yohimbine for Antagonism of Xylazine in Mice Anesthetized with Ketamine and Xylazine.

التفاصيل البيبلوغرافية
العنوان: Comparison of Atipamezole with Yohimbine for Antagonism of Xylazine in Mice Anesthetized with Ketamine and Xylazine.
المؤلفون: Janssen CF; Division of Laboratory Animal Resources, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, Center for Laboratory Animal Medicine and Care, University of Texas Health Science Center at Houston, Houston, Texas;, Email: Christopher.F.Janssen@uth.tmc.edu., Maiello P; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Wright MJ Jr; Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Kracinovsky KB; Division of Laboratory Animal Resources, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Newsome JT; Division of Laboratory Animal Resources, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
المصدر: Journal of the American Association for Laboratory Animal Science : JAALAS [J Am Assoc Lab Anim Sci] 2017 Mar 01; Vol. 56 (2), pp. 142-147.
نوع المنشور: Controlled Clinical Trial; Journal Article
اللغة: English
بيانات الدورية: Publisher: American Association for Laboratory Animal Science Country of Publication: United States NLM ID: 101269489 Publication Model: Print Cited Medium: Internet ISSN: 2769-6677 (Electronic) Linking ISSN: 15596109 NLM ISO Abbreviation: J Am Assoc Lab Anim Sci Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Memphis, TN : American Association for Laboratory Animal Science, [2006]-
مواضيع طبية MeSH: Imidazoles/*pharmacology , Ketamine/*pharmacology , Xylazine/*pharmacology , Yohimbine/*pharmacology, Adrenergic alpha-2 Receptor Antagonists/administration & dosage ; Adrenergic alpha-2 Receptor Antagonists/pharmacology ; Analgesics/administration & dosage ; Analgesics/pharmacology ; Anesthesia ; Animals ; Cross-Over Studies ; Imidazoles/administration & dosage ; Ketamine/administration & dosage ; Laboratory Animal Science ; Male ; Mice ; Xylazine/administration & dosage ; Yohimbine/administration & dosage
مستخلص: The α2 adrenergic agonist xylazine produces a sedative effect and is typically combined with ketamine and used for anesthesia or chemical restraint of laboratory mice. Xylazine's sedative effect-and its undesirable side effects of bradycardia, hypotension, and poor tissue perfusion-can be reversed by administration of α2 antagonists, such as atipamezole or yohimbine. Although atipamezole and yohimbine dosing guidelines are available for mice, no controlled comparison has been performed to guide the lab animal community in the selection of one over the other. This study is a single-dose crossover comparison of these 2 antagonist drugs, given intraperitoneally at clinically recommended doses, to determine which results in more rapid recovery of mice from xylazine-ketamine anesthesia. Time to return of righting reflex was used as the primary outcome measure. Mice were anesthetized with xylazine (10 mg/kg IP) and ketamine (80 mg/kg IP), followed 15 min later by injection of an α2 antagonist or saline (control). Time to return of righting reflex differed significantly among groups, with mice recovering in an average of 10.3 min after administration of atipamezole (1 mg/kg IP) as compared with 21.3 min after yohimbine (1.5 mg/kg IP) and 38.2 min after saline. When rapid recovery of mice after xylazine-ketamine anesthesia is desirable, administration of an antagonist to reverse the effects of the xylazine is indicated. When injection of the antagonist by the technically simple intraperitoneal route is desirable, our data indicate that (at the doses evaluated) atipamezole is more effective than yohimbine.
References: CNS Drug Rev. 2005 Autumn;11(3):273-88. (PMID: 16389294)
J Am Assoc Lab Anim Sci. 2013 Jul;52(4):481-7. (PMID: 23849447)
J Am Assoc Lab Anim Sci. 2009 May;48(3):296-9. (PMID: 19476720)
PLoS One. 2014 Jul 22;9(7):e100323. (PMID: 25050866)
Comp Med. 2001 Oct;51(5):443-56. (PMID: 11924805)
Vet Anaesth Analg. 2005 Sep;32(5):261-70. (PMID: 16135207)
Eur J Pharmacol. 1982 Sep 10;83(1-2):55-60. (PMID: 7128700)
Biol Psychiatry. 2005 Jan 1;57(1):33-43. (PMID: 15607298)
Can J Vet Res. 1988 Oct;52(4):411-5. (PMID: 2904298)
J Vet Med Sci. 2009 May;71(5):539-48. (PMID: 19498277)
Comp Med. 2004 Dec;54(6):652-5. (PMID: 15679263)
Curr Top Med Chem. 2007;7(2):163-86. (PMID: 17266604)
Can J Vet Res. 2003 Jan;67(1):64-7. (PMID: 12528832)
J Am Assoc Lab Anim Sci. 2008 Jan;47(1):11-7. (PMID: 18210992)
J Vet Pharmacol Ther. 1995 Oct;18(5):328-32. (PMID: 8587149)
Lab Anim. 2009 Apr;43(2):149-54. (PMID: 19116297)
J Med Primatol. 2009 Dec;38(6):404-10. (PMID: 19735352)
PLoS One. 2012;7(3):e32645. (PMID: 22427858)
Can J Vet Res. 2009 Oct;73(4):260-70. (PMID: 20046627)
Acta Vet Scand Suppl. 1989;85:193-7. (PMID: 2571273)
Br J Clin Pharmacol. 1991 Feb;31(2):160-5. (PMID: 1675577)
Am J Vet Res. 1991 Apr;52(4):585-8. (PMID: 2053729)
BMC Vet Res. 2014 Aug 23;10:198. (PMID: 25149627)
J Vet Pharmacol Ther. 1998 Oct;21(5):342-7. (PMID: 9811433)
J Wildl Dis. 2004 Jul;40(3):533-7. (PMID: 15465721)
J Pharmacol Exp Ther. 2000 Apr;293(1):1-7. (PMID: 10734146)
Lab Anim. 1998 Jan;32(1):18-22. (PMID: 9481690)
Vet Clin North Am Exot Anim Pract. 2000 Jan;3(1):221-37, viii. (PMID: 11228829)
Altern Lab Anim. 2005 Apr;33(2):119-27. (PMID: 16180987)
J Am Assoc Lab Anim Sci. 2011 Nov;50(6):916-20. (PMID: 22330787)
J Am Vet Med Assoc. 1989 Aug 1;195(3):378-81. (PMID: 2570052)
المشرفين على المادة: 0 (Adrenergic alpha-2 Receptor Antagonists)
0 (Analgesics)
0 (Imidazoles)
03N9U5JAF6 (atipamezole)
2KFG9TP5V8 (Xylazine)
2Y49VWD90Q (Yohimbine)
690G0D6V8H (Ketamine)
تواريخ الأحداث: Date Created: 20170320 Date Completed: 20170816 Latest Revision: 20240525
رمز التحديث: 20240525
مُعرف محوري في PubMed: PMC5361038
PMID: 28315642
قاعدة البيانات: MEDLINE